Table 1. Relationship between SALL4 expression and clinicopathologic characteristics in endometrial cancer (n = 80).

Parameter	N	Positive (%)	P
Age
≤50	33	22 (66.7%)	0.586
>50	47	34 (72.3%)
FIGO stage
I-II	52	30 (57.7%)	0.001
III-IV	28	26 (92.9%)
Histological grade
G1	38	29 (76.3%)	0.309
G2	29	20 (69.0%)
G3	13	7 (53.9%)
Lymph node metastasis
Positive	26	22 (84.6%)	0.048
Negative	54	34 (63.0%)
Myometrial invasion
≤1/2	45	26 (57.8%)	0.007
>1/2	35	30 (85.7%)